Screener
Aclaris Therapeutics ACRS Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
FAQ
- What is Aclaris Therapeutics's book value per share?
- Aclaris Therapeutics (ACRS) reported book value per share of $0.87 in Q2 2026.
- How has Aclaris Therapeutics's book value per share changed year-over-year?
- Aclaris Therapeutics's book value per share decreased by 18.8% year-over-year, from $1.07 to $0.87.
- What is the long-term trend for Aclaris Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's book value per share has grown at a -1.0% compound annual growth rate (CAGR), from $0.89 to $0.84.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Aclaris Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude